Skip to main content
. 2020 Jan 1;11(3):570–582. doi: 10.7150/jca.35631

Table 1.

Clinical characteristics and prognostic factors analysis for 86 HCCs

Variables No. of patients χ2 P value
High p-STAT3 group Low p-STAT3 group
Age (years) ≤50 15 8 0.167 0.683
>50 44 19
Gender Female 20 13 1.591 0.207
Male 39 14
Liver cirrhosis No 7 2 0.393 0.531
Yes 52 25
AFP level (ng/mL) ≤400 12 9 1.695 0.193
>400 47 18
HBV infection No 18 15 4.914 0.027
Yes 41 12
TNM I+II 9 4 0.003 0.958
III+IV 50 23
Tumor diameter (cm) ≤5 17 15 5.670 0.017
>5 42 12
Intrahepatic metastases Single 13 12 4.512 0.034
Multiple 46 15
PVTT Present 43 12 6.498 0.011
Absent 16 15
Tumor differentiation I+II 19 15 4.216 0.039
III+IV 40 12
TACE times 1 24 9 0.423 0.516
>1 35 18